4.0 Article

Long-term outcome of patients undergoing in-vitro fertilisation in France: The outcome study

出版社

ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.jogoh.2020.101968

关键词

Cumulative live birth rate; IVF; Dropout rate; Time to pregnancy

资金

  1. Merck Sante S.A.S., a subsidiary of Merck KGaA, Darmstadt, Germany

向作者/读者索取更多资源

The outcome study investigated the cumulative live birth rate per patient (CLBR) and found significant variations between different IVF centers, influenced by factors such as patient age, parity, number of oocytes, smoking habits, and overweight. The differences in performance between centers remained even after adjusting for these indicators, indicating that the differences were not solely due to differences in the patient population.
The Outcome study examines the fate of 4083 patients beginning IVF in 41 IVF centres, between January 2010 and December 2013. Cumulative live birth rate per patient (CLBR), the best reflection of IVF efficacy, is rarely presented in publications as it requires long-term follow-up, including all successive cycles, and pregnancies outcome. Analysis of international publications shows an average CLBR of 41.6 % and a drop-out rate of 49.5 %, both greatly varying by country and IVF centres. Because of the frequency with which patients change centre (8%), the Outcome study distinguishes patients with a past history of IVF in another centre (CLBR = 47.2 %) and patients undergoing their first true cycle (CLBR = 56.4 %). Survival techniques by Competing Risk, intended to take account of drop-out and lost to follow-up, assessed the overall CLBR as being 65.4 %. Differences in performance between centres are considerable for both CLBR (32-64%) and Performance Index, taking account of the number of cycles required to achieve a pregnancy (2-5). Multiple variance logistic regression analysis shows that the indicators influencing performance are age, parity, number of oocytes, smoking habit and overweight. These indicators are independent each other and are influencing performance in a high significant way. After adjusting for these indicators, the differences between centres are reduced but remain large and very significant. No centre appears to have specific expertise in the management of patients with adverse indicators. The Outcome study therefore confirms that the large differences in performance between centres are not explained by a difference in the treated population. (c) 2020 Published by Elsevier Masson SAS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据